Search All Tech Briefings

Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available.  Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 1184 Results

Intervention Indication Therapeutic Area Year Actions
131I-omburtamab for neuroblastoma with central nervous system or leptomeningeal metastasis in paediatric patients Omburtamab I-131 (131I-mu8H9) Neuroblastoma Neurological Cancer 2019 View  |  Download
177Lu-PSMA-617 for metastatic castrationresistant prostate cancer - third line Lutetium (177Lu-PSMA-617; 177Lu-DOTA-tyr3-octreotate; Lutathera) Prostate cancer Male Reproductive Cancer 2020 View  |  Download
A4250 for progressive familial intrahepatic cholestasis Odevixibat (A4250) Progressive familial intrahepatic cholestasis (PFIC) Genetic Disorders , Hepatology 2017 View  |  Download
Abaloparatide for treating osteoporosis in males aged 40 to 85 years Abaloparatide (Tymlos; BA058) Osteoporosis Musculoskeletal System 2021 View  |  Download
Abatacept for treating idiopathic inflammatory myopathies Abatacept (Orencia) Idiopathic inflammatory myopathies Immunology , Musculoskeletal System 2022 View  |  Download
Abatacept with a calcineurin inhibitor and methotrexate for prophylaxis of acute graft versus host disease Abatacept (Orencia) Graft versus host disease (GvHD) Immunology 2022 View  |  Download
ABBV-951 for motor fluctuations in Parkinson’s disease ABBV-951 (fixed dose combination: Carbidopa; Levodopa) Parkinson's disease Neurology 2020 View  |  Download
Abemaciclib for early breast cancer – adjuvant treatment Abemaciclib (LY2835219; Verzenio; CC-115) Breast cancer Breast Cancer 2020 View  |  Download
Abemaciclib in combination with fulvestrant for advanced or metastatic breast cancer after prior endocrine therapy Abemaciclib (LY2835219; Verzenio; CC-115) , Fulvestrant (Faslodex) Breast cancer Breast Cancer 2017 View  |  Download
Abemaciclib with abiraterone acetate and prednisone for metastatic castration-resistant prostate cancer Abemaciclib (LY2835219; Verzenio; CC-115) , Abiraterone acetate (Zytiga; Yonsa) , Prednisone (Decadron; Lodotra) Prostate cancer Male Reproductive Cancer 2022 View  |  Download
1 2 3 118 119
Medicine Industry's Gateway to NICE
Support for Industry
Outputs & Publications